United States · Bill · HR
H.R. 3320 (98th)
A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.
Introduced
15 June 1983
Last action
—
Status
Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
Sponsors
—
Subjects
Discovery layer
Source updated
16 January 2025
Summary
Amends the Trade-Mark Act of 1946 to permit same-use approved equivalent drugs to be manufactured in the form of a tablet which is the same size, color, and shape of the tablet of another drug without violating the prohibitions against false designations of origin or false descriptions or representations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
summary · EN · 15 June 1983
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/98th-congress/house-bill/3320
- Open data entity: https://api.congress.gov/v3/bill/98/hr/3320